Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
Table 2
Relative risks (RRs) of grade 3–4 adverse events for patients who received BP in addition to standard therapy vs those who received standard therapy only.